Divyesh Joshi

Divyesh Joshi

Auto-generated profile, based on publicly available information

Divyesh Joshi

Section of Cardiovascular Medicine, Yale Cardiovascular Research Center, Department of Internal Medicine, School of Medicine, Yale University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2024 in The EMBO Journal
Verified
Journal Article
Open access
KTKeiichiro Tanaka
Keiichiro Tanaka
MCMinghao Chen
Minghao Chen
APAndrew Prendergast
Andrew Prendergast
ZZZhenwu Zhuang
Zhenwu Zhuang
ANAli Nasiri
Ali Nasiri
MSMartin Alexander Schwartz
Martin Alexander Schwartz
Endothelial cell responses to fluid shear stress from blood flow are crucial for vascular development, function, and disease. A complex of PECAM-1, VE-cadherin, VEGF receptors (VEGFRs), and Plexin D1 located at cell–cell junctions mediates many of these events. However, available evidence suggests that another mechanosensor upstream of PECAM-1 initiates signaling. Hypothesizing that GPCR and Gα proteins may serve this role, we performed siRNA screening of Gα subunits and found that Gαi2 and Gαq/11 are required for activation of the junctional complex. We then developed a new activation assay, which showed that these G proteins are activated by flow. We next mapped the Gα residues required for activation and developed an affinity purification method that used this information to identify latrophilin-2 (Lphn2/ADGRL2) as the upstream GPCR. Latrophilin-2 is required for all PECAM-1 downstream events tested. In both mice and zebrafish, latrophilin-2 is required for flow-dependent angiogenesis and artery remodeling. Furthermore, endothelial-specific knockout demonstrates that latrophilin plays a role in flow-dependent artery remodeling. Human genetic data reveal a correlation between the latrophilin-2-encoding Adgrl2 gene and cardiovascular disease. Together, these results define a pathway that connects latrophilin-dependent G protein activation to subsequent endothelial signaling, vascular physiology, and disease.

4 September 2024 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
DJDivyesh Joshi
Divyesh Joshi
BCBrian G. Coon
Brian G. Coon
RCRaja Chakraborty
Raja Chakraborty
HDHanqiang Deng
Hanqiang Deng
ZYZiyu Yang
Ziyu Yang
MSMartin Alexander Schwartz
Martin Alexander Schwartz
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality worldwide. Laminar shear stress from blood flow, sensed by vascular endothelial cells, protects from ASCVD by upregulating the transcription factors KLF2 and KLF4, which induces an anti-inflammatory program that promotes vascular resilience. Here we identify clustered γ-protocadherins as therapeutically targetable, potent KLF2 and KLF4 suppressors whose upregulation contributes to ASCVD. Mechanistic studies show that γ-protocadherin cleavage results in translocation of the conserved intracellular domain to the nucleus where it physically associates with and suppresses signaling by the Notch intracellular domain. γ-Protocadherins are elevated in human ASCVD endothelium; their genetic deletion or antibody blockade protects from ASCVD in mice without detectably compromising host defense against bacterial or viral infection. These results elucidate a fundamental mechanism of vascular inflammation and reveal a method to target the endothelium rather than the immune system as a protective strategy in ASCVD.

3 January 2025 in Science Advances
Verified
Journal Article
Open access
HDHanqiang Deng
Hanqiang Deng
OROleksii S. Rukhlenko
Oleksii S. Rukhlenko
DJDivyesh Joshi
Divyesh Joshi
XHXiaoyue Hu
Xiaoyue Hu
PJPhilipp Junk
Philipp Junk
MSMartin Alexander Schwartz
Martin Alexander Schwartz
Fluid shear stress (FSS) from blood flow sensed by vascular endothelial cells (ECs) determines vessel behavior, but regulatory mechanisms are only partially understood. We used cell state transition assessment and regulation (cSTAR), a powerful computational method, to elucidate EC transcriptomic states under low shear stress (LSS), physiological shear stress (PSS), high shear stress (HSS), and oscillatory shear stress (OSS) that induce vessel inward remodeling, stabilization, outward remodeling, or disease susceptibility, respectively. Combined with a publicly available database on EC transcriptomic responses to drug treatments, this approach inferred a regulatory network controlling EC states and made several notable predictions. Particularly, inhibiting cell cycle–dependent kinase (CDK) 2 was predicted to initiate inward remodeling and promote atherogenesis. In vitro, PSS activated CDK2 and induced late G 1 cell cycle arrest. In mice, EC deletion of CDK2 triggered inward artery remodeling, pulmonary and systemic hypertension, and accelerated atherosclerosis. These results validate use of cSTAR and identify key determinants of normal and pathological artery remodeling.

8 July 2024 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
HDHanqiang Deng
Hanqiang Deng
JZJiasheng Zhang
Jiasheng Zhang
YWYewei Wang
Yewei Wang
DJDivyesh Joshi
Divyesh Joshi
XPXinchun Pi
Xinchun Pi
MSMartin Alexander Schwartz
Martin Alexander Schwartz

27 March 2026 in Circulation Research
Verified
Journal Article
Closed access
HDHanqiang Deng
Hanqiang Deng
XZXing Zhang
Xing Zhang
YWYewei Wang
Yewei Wang
DJDivyesh Joshi
Divyesh Joshi
GTGeorge Tellides
George Tellides
MSMartin Alexander Schwartz
Martin Alexander Schwartz
BACKGROUND: Atherosclerosis occurs preferentially in regions of disturbed fluid shear stress (FSS), whereas physiological laminar FSS protects against disease by suppressing endothelial inflammation. Proinflammatory versus anti-inflammatory programs are associated with glycolysis versus oxidative phosphorylation, respectively, but mechanisms are poorly understood. The TF (transcription factor) FOXO1 (forkhead box protein O1) is known to regulate endothelial metabolism and angiogenesis, but little is known about its role in endothelial inflammation. METHODS: Endothelial cells were treated with cytokines or subjected to defined flow patterns in vitro using a parallel plate flow chamber. Immunofluorescence, RNA sequencing, and biochemical assays assessed FOXO1 localization, gene expression, and posttranslational modifications. In vivo experiments used FOXO1-floxed mice crossed with Bmx-CreER T2 (bone marrow kinase on chromosome X- Cre recombinase estrogen receptor fusion) for artery endothelial cell–specific FOXO1 knockout. Hyperlipidemia was induced via injection of PCSK9 (proprotein convertase subtilisin/kexin type 9) adeno-associated virus and high-cholesterol/high-fat diet to assess atherosclerosis. RESULTS: Oscillatory FSS and inflammatory cytokines induced whereas physiological FSS inhibited FOXO1 nuclear translocation. Depleting FOXO1 in endothelial cells upregulated the protective flow-responsive TFs KLF2/4 (Krüppel-like factor 2 and 44) and reduced oscillatory FSS-induced inflammatory genes. Inhibition of FOXO1 nuclear translocation by physiological FSS is mediated via a KLF2-CDK2 (cell cycle–dependent kinase 2) pathway, with the latter phosphorylating FOXO1 at S249 (Serine 249). Artery endothelial cell–specific deletion of FOXO1 significantly reduced atherosclerotic plaques in hyperlipidemic mice. Inhibition of glycolysis blocked oscillatory shear stress–induced FOXO1 nucleus translocation, while treatment with lactate promoted FOXO1 nuclear localization. These effects required lactyltransferase AARS1 (alanyl-tRNA synthetase 1) and correlated with FOXO1 lactylation. CONCLUSIONS: These findings identify FOXO1 as a key mediator linking atheroprone flow and endothelial inflammatory gene expression via lactate-driven lactylation and nuclear translocation, promoting atherosclerosis. Conversely, physiological FSS suppresses FOXO1 via KLF2-CDK2 signaling. These complementary pathways suggest potential new therapeutic targets for treating atherosclerotic cardiovascular disease.

24 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DCDongying Chen
Dongying Chen
OROleksii S. Rukhlenko
Oleksii S. Rukhlenko
DJDivyesh Joshi
Divyesh Joshi
MRMartina Rudnicki
Martina Rudnicki
BCBrian G. Coon
Brian G. Coon
MSMichael Simons
Michael Simons
Postnatal vascular morphogenesis is a dynamic process that initially involves angiogenesis to form the capillary bed, followed by its partial remodeling into arteries. Vascular endothelial growth factor A (VEGF hereafter), the primary inducer of angiogenesis, is also implicated in arterial specification in developmental contexts. However, it is unclear why arterial patterning is spatiotemporally segregated from angiogenesis, while postnatal arterial specification in animal models with blocked VEGF signaling remains unstudied. Here, we report that VEGF does not induce arterial fate in the capillaries, instead serving as a physiological brake to attenuate fluid shear stress (FSS)-driven capillary-to-arterial cell fate transition. Mouse models with disrupted VEGF signaling reveal impaired angiogenesis but intact and ectopic arterialization. Mechanistically, mechanosensitive transcription factor Sox17 determines the FSS-arterial program, while VEGF suppresses Sox17 transcription activity at arterial promoters and enhancers sites. Angiogenic signaling, while essential for the initial capillary morphogenesis, inhibits arterial specification, thereby protecting the capillary bed from premature arterialization driven by flow. These findings establish a new paradigm in which precise spatiotemporal coordination of environmental stimuli orchestrates angiogenesis, arterial patterning and capillary maintenance during vascular morphogenesis.